Attached files
| file | filename |
|---|---|
| EX-21 - AIM ImmunoTech Inc. | ex21.htm |
| EX-5.1 - AIM ImmunoTech Inc. | ex5-1.htm |
| S-1 - AIM ImmunoTech Inc. | forms-1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in this Registration Statement on Form S-1 of Hemispherx Biopharma, Inc. our report dated March 31, 2017, relating to the consolidated financial statements of Hemispherx Biopharma, Inc. and subsidiaries, appearing in the Annual Report on Form 10-K of Hemispherx Biopharma, Inc. for the year ended December 31, 2016.
We also consent to the reference to our firm under the heading “Experts” in such Prospectus, which is a part of this Registration Statement.
| /s/ RSM US LLP | |
| Blue Bell, Pennsylvania | |
| September 29, 2017 |